Diouf O, Depreux P, Chavatte P, Poupaert J H
Institut de chimie pharmaceutique Albert Lespagnol, 3, rue du Professeur Laguesse, BP 83, 59006 cedex, Lille, France.
Eur J Med Chem. 2000 Jul-Aug;35(7-8):699-706. doi: 10.1016/s0223-5234(00)00163-x.
The indole derivative GR 113808 is currently used as the reference ligand for labelling the 5-HT(4) serotoninergic receptors. Previous works in our laboratories established the bioisosteric equivalency of the indole heterocycle and naphthalene in a series of melatonin receptor ligands. Based on this knowledge we designed new analogues of GR 113808 by introducing two bioisosteric modifications: firstly, the indole ring was replaced by a naphthalene one and secondly, the ester linkage was replaced by an amide group. Compound 8 emerged within this novel series as it displayed high and selective affinity at 5-HT(4) receptors (Ki 5-HT(4) = 6 nM, Ki 5-HT(3) = 100 nM, Ki values at other 5-HT receptors were higher than 1000 nM). Compound 8 is currently undergoing further pharmacological evaluation.
吲哚衍生物GR 113808目前用作标记5-HT(4) 5-羟色胺能受体的参考配体。我们实验室先前的研究确定了一系列褪黑素受体配体中吲哚杂环与萘的生物电子等排等效性。基于这一认识,我们通过引入两种生物电子等排修饰设计了GR 113808的新类似物:首先,用萘环取代吲哚环;其次,用酰胺基团取代酯键。化合物8在这个新系列中脱颖而出,因为它在5-HT(4)受体上表现出高选择性亲和力(Ki 5-HT(4) = 6 nM,Ki 5-HT(3) = 100 nM,在其他5-HT受体上的Ki值高于1000 nM)。化合物8目前正在进行进一步的药理学评估。